Visit COVID-19 resources

[Skip to Content]

Comment on ‘Evaluation of choroidal thickness in patients with scleroderma’ – (Eye 30, 1398 (October 2016))

Oct 06
2016

Comment on ‘Evaluation of choroidal thickness in patients with scleroderma’ Eye 30, 1398 (October 2016). doi:10.1038/eye.2016.101 Author: S Uzun

  • 6 October 2016

Reply to: ‘Comment on Evaluation of choroidal thickness in patients with scleroderma’ – (Eye 30, 1399 (October 2016))

Oct 06
2016

Reply to: ‘Comment on Evaluation of choroidal thickness in patients with scleroderma’ Eye 30, 1399 (October 2016). doi:10.1038/eye.2016.102 Authors: E Coşkun, O Zengin, S Kenan, G Kimyon, K Erdogan Er, S Okumus, A Mesut Onat, I Erbagcı & B Kısacık

  • 6 October 2016

Can general A&E doctors manage common eye emergencies? – (Eye 30, 1399 (October 2016))

Oct 06
2016

Can general A&E doctors manage common eye emergencies? Eye 30, 1399 (October 2016). doi:10.1038/eye.2016.99 Authors: P I Murray, M Benjamin & O Oyede

  • 6 October 2016

Uveitic macular edema – (Eye 30, 1277 (October 2016))

Oct 06
2016

Uveitic macular edema Eye 30, 1277 (October 2016). doi:10.1038/eye.2016.115 Authors: C Fardeau, E Champion, N Massamba & P LeHoang

  • 6 October 2016

Revisiting the role of erythropoietin for treatment of ocular disorders – (Eye 30, 1293 (October 2016))

Oct 06
2016

Revisiting the role of erythropoietin for treatment of ocular disorders Eye 30, 1293 (October 2016). doi:10.1038/eye.2016.94 Authors: S L Shirley Ding, S N Leow, R Munisvaradass, E H Koh, M L C Bastion, K Y Then, S Kumar & P L Mok

  • 6 October 2016